The YAP1 target gene signature derived from stable mammary epithelial cell lines was thus further refined based on tumor tissue gene expression correlation with YAP1 and association with aggressive clinical features and survival outcomes of breast cancer patients in two publicly available datasets; METBRIC and TCGA. This evidence concerns the gene YAP1 and neoplasm.